This report on hERG Screening presents an in depth analysis of hERG Screening market. The study emphasizes on both technology and product segments of hERG Screening in biotechnology and pharmaceutical application areas. The report provides essential information including market data, segmentation, market size, key trends, M&A, product developments, industry forecasts, corporate intelligence, and other relevant information. http://bharatbook.com/market-research-reports/biotechnology-market-research-report/herg-screening.html
 
 The report lists more than 120 companies that are engaged in hERG Screening services and/or production of hERG screening tools/instruments. A global perspective is presented along with regional analysis covering North America, Europe, Asia-Pacific and Rest of World. Compilation of Worldwide Patents and Research related to hERG Screening is also provided. The market is analyzed in US Dollars and includes 40 exclusive graphically illustrated exhibits. Market Research Companies
 
 Report Highlights
 
 This report may help strategists, investors, laboratories, contract research organizations, biotechnology & Healthcare companies, academic professionals, drug approval authorities, and other organizations to –
 * Identify Market Opportunities
 * Review and Analyze Global and Regional Markets
 * Gauge Market Potential for your Products
 * Identify Competition
 * Use Market Research for exploring new areas
 * Acquire Meaningful Guidelines for Strategic Planning
 * Gear up for Market Entry
 * Get Actionable Information
 
 Analytics and data presented in each report pertain to several parameters such as –
 * Global and Regional Market Sizes, Market Shares, Market Trends
 * Product (Global and Regional) Market Sizes, Market Shares, Market Trends
 * Technology Trends
 * Corporate Intelligence
 * Key Companies By Sales, Brands, Products
 * Other Strategic Business Affecting Data
 
 Key Report Findings
 Human Ether-a-go-go Related Gene (hERG gene) (KCNH2) is an encoder of the potassium ion channel that repolarizes IKr current in the heart. It consists of 6 transmembrane domains which are serially numbered from S1-S6. The abnormalities resulting in this channel can either lead to Long QT syndrome (LQT2) or Short QTsyndrome causing loss of function mutations and gain of function mutations respectively. Both of these are considered as potentially fatal cardiac arrhythmia caused due to repolarisation disturbances of the cardiac action potential.
 
 Global hERG Screening market is projected to grow at 28.97%, compounded annually from 2005 through 2015. hERG Screening has its major role in the pharmaceutical field in drug release process. Some drugs may prolong the QT interval in normal and healthy individuals and result in QT Syndrome. This side effect has promoted majority of pharmaceutical companies to screen compounds for hERG channel activity in early stages of drug discovery and development process. Many companies are developing cell lines such as HEK 293, and CHO to aid in vitro screening for hERG channel activity.
 
 For more information kindly visit :
 Report on hERG Screening presents an in depth analysis
 
 Or
 
 Bharat Book Bureau
 Tel: +91 22 27810772 / 27810773
 Fax: + 91 22 27812290
 Email: info@bharatbook.com
 Website: www.bharatbook.com
 Follow us on twitter: http://twitter.com/#!/Sandhya3B